MANKIND PHARMA
|
The Current P/E Ratio of MANKIND PHARMA is 52.65.
Share Price | ₹2,430.9 | Aug 12,2025 |
Market Cap | ₹100,321.2 Cr | |
Earnings-TTM | ₹1,905.5 Cr | TTM-Consolidated Results |
Price/Earnings | 52.65x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of MANKIND PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹100,321.2 Cr] as on Aug 12,2025
(/) Earnings [ ₹1,905.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 52.65x ]
Thus, for MANKIND PHARMA , the investors are currently willing to pay 52.65 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MANKIND PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MANKIND PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of MANKIND PHARMA
PE Ratio Performance Analysis for MANKIND PHARMA
- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 19.67x.
- MANKIND PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2025 at 50.22x.
- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does MANKIND PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
MANKIND PHARMA | 1,905.51 | 52.65 | 100,321.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.38 | 389,172.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 68.62 | 158,248.0 |
CIPLA LTD | 5,406.81 | 22.72 | 122,835.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.34 | 122,793.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 17.79 | 101,869.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 20.74 | 96,206.0 |
LUPIN LTD | 3,722.18 | 23.85 | 88,782.5 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.98 | 61,448.8 |
ABBOTT INDIA LTD | 1,452.29 | 47.32 | 68,724.7 |
ALKEM LABORATORIES LTD | 2,334.08 | 26.38 | 61,583.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MANKIND PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.79x |
Max industry PE | 68.62x |
Median industry PE | 26.38x |
Average industry PE | 36.07x |
You may also like the below Video Courses